Nexthera Capital’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q3
Sell
-99,110
Closed -$12.9M 59
2017
Q2
$12.9M Sell
99,110
-20,890
-17% -$2.56M 5.61% 5
2017
Q1
$14.9M Sell
120,000
-2,000
-2% -$239K 7.62% 4
2016
Q4
$14.1M Buy
+122,000
New +$13.6M 8.28% 3
2016
Q2
Sell
-135,000
Closed -$13.5M 47
2016
Q1
$13.5M Buy
135,000
+55,000
+69% +$5.66M 14% 1
2015
Q4
$9.58M Buy
+80,000
New +$9.26M 13.59% 3

Other funds holding CELG

Nexthera Capital's CELG Position: Q3 2017 in Review

Nexthera Capital sold out of Celgene Corp (CELG) in Q3 2017, closing a stake of 99,110 shares — an estimated $12.9M sold.

Nexthera Capital first reported a position in CELG in Q4 2015 and held it in 5 quarters. The position peaked at $14.9M in Q1 2017. 1,484 funds tracked by Wall St. Rank hold CELG as of Q3 2017.

  • Nexthera Capital reported no remaining Celgene Corp position as of Q3 2017 after selling out during the quarter.
  • Nexthera Capital sold 99,110 Celgene Corp shares in Q3 2017, an estimated $12.9M.
  • Nexthera Capital first reported a position in Celgene Corp in Q4 2015 and held it in 5 quarters.
  • Nexthera Capital's Celgene Corp position peaked at $14.9M in Q1 2017.
  • 1,484 funds tracked by Wall St. Rank held Celgene Corp as of Q3 2017.

Based on Nexthera Capital's 13F filing for Q3 2017, filed 14 Nov 2017.